EE200000342A - Azethanes derived from azacycloalkanes, their thio and dithio analogs, their preparation and their use as 2,3-epoxy squalene-lesterol cyclase inhibitors - Google Patents

Azethanes derived from azacycloalkanes, their thio and dithio analogs, their preparation and their use as 2,3-epoxy squalene-lesterol cyclase inhibitors

Info

Publication number
EE200000342A
EE200000342A EEP200000342A EEP200000342A EE200000342A EE 200000342 A EE200000342 A EE 200000342A EE P200000342 A EEP200000342 A EE P200000342A EE P200000342 A EEP200000342 A EE P200000342A EE 200000342 A EE200000342 A EE 200000342A
Authority
EE
Estonia
Prior art keywords
azethanes
lesterol
azacycloalkanes
thio
derived
Prior art date
Application number
EEP200000342A
Other languages
Estonian (et)
Inventor
Maier Roland
M�ller Peter
Schilcher Gebhard
Adelgoss Gebhard
Hurnaus Rudolf
Mark Michael
Eisele Bernhard
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200000342A publication Critical patent/EE200000342A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Cardiology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
EEP200000342A 1997-12-10 1998-12-08 Azethanes derived from azacycloalkanes, their thio and dithio analogs, their preparation and their use as 2,3-epoxy squalene-lesterol cyclase inhibitors EE200000342A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754796A DE19754796A1 (en) 1997-12-10 1997-12-10 Novel azacycloalkane-derived urethanes, their thio and dithio analogues, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation
PCT/EP1998/007965 WO1999029669A1 (en) 1997-12-10 1998-12-08 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors

Publications (1)

Publication Number Publication Date
EE200000342A true EE200000342A (en) 2001-08-15

Family

ID=7851381

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000342A EE200000342A (en) 1997-12-10 1998-12-08 Azethanes derived from azacycloalkanes, their thio and dithio analogs, their preparation and their use as 2,3-epoxy squalene-lesterol cyclase inhibitors

Country Status (27)

Country Link
EP (1) EP1060162B1 (en)
JP (1) JP3418688B2 (en)
KR (1) KR20010032977A (en)
CN (1) CN1281434A (en)
AR (1) AR017827A1 (en)
AT (1) ATE234816T1 (en)
AU (1) AU1759499A (en)
BG (1) BG104500A (en)
BR (1) BR9813495A (en)
CA (1) CA2309388A1 (en)
CO (1) CO5370694A1 (en)
DE (2) DE19754796A1 (en)
DK (1) DK1060162T3 (en)
EA (1) EA200000631A1 (en)
EE (1) EE200000342A (en)
ES (1) ES2190130T3 (en)
HR (1) HRP20000377A2 (en)
HU (1) HUP0100335A3 (en)
IL (1) IL135738A0 (en)
NO (1) NO20002967L (en)
PL (1) PL341060A1 (en)
PT (1) PT1060162E (en)
SK (1) SK8612000A3 (en)
TR (1) TR200001635T2 (en)
WO (1) WO1999029669A1 (en)
YU (1) YU35600A (en)
ZA (1) ZA9811262B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072865A1 (en) * 2001-01-15 2004-04-15 Bouillot Anne Marie Jeanne Aryl piperidine derivatives as inducers of ldl-receptor expression
JP2004520347A (en) * 2001-01-15 2004-07-08 グラクソ グループ リミテッド Arylpiperidine and piperazine derivatives as inducers of LDL-receptor expression
EP1351937A1 (en) * 2001-01-15 2003-10-15 Glaxo Group Limited Aryl piperidine derivatives as inducers of ldl-receptor expression
DE10132686A1 (en) * 2001-07-05 2003-01-16 Boehringer Ingelheim Pharma Heteroarylcarboxamides, their preparation and their use as medicines
JP4664634B2 (en) * 2003-09-05 2011-04-06 富山化学工業株式会社 Novel benzamidine derivatives or salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04312572A (en) * 1991-04-12 1992-11-04 Takeda Chem Ind Ltd Cyclic amine compound
DE4407138A1 (en) 1994-03-04 1995-09-07 Thomae Gmbh Dr K Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation
DE4407136A1 (en) 1994-03-04 1995-09-07 Thomae Gmbh Dr K New amino:methyl substd. aroyl-aza:cycloalkane derivs.

Also Published As

Publication number Publication date
HUP0100335A3 (en) 2001-11-28
EP1060162A1 (en) 2000-12-20
BR9813495A (en) 2000-10-10
DE19754796A1 (en) 1999-06-17
CN1281434A (en) 2001-01-24
DK1060162T3 (en) 2003-07-14
HUP0100335A2 (en) 2001-07-30
JP2001525397A (en) 2001-12-11
CO5370694A1 (en) 2004-02-27
WO1999029669A1 (en) 1999-06-17
KR20010032977A (en) 2001-04-25
HRP20000377A2 (en) 2000-12-31
PL341060A1 (en) 2001-03-26
TR200001635T2 (en) 2000-11-21
YU35600A (en) 2002-09-19
PT1060162E (en) 2003-08-29
DE59807591D1 (en) 2003-04-24
JP3418688B2 (en) 2003-06-23
ZA9811262B (en) 2000-06-09
NO20002967D0 (en) 2000-06-09
NO20002967L (en) 2000-08-09
SK8612000A3 (en) 2000-11-07
AU1759499A (en) 1999-06-28
ES2190130T3 (en) 2003-07-16
BG104500A (en) 2001-03-30
ATE234816T1 (en) 2003-04-15
AR017827A1 (en) 2001-10-24
EP1060162B1 (en) 2003-03-19
EA200000631A1 (en) 2000-12-25
IL135738A0 (en) 2001-05-20
CA2309388A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
DE69616804D1 (en) WATER-DISPERSIBLE COPOLYESTER-ETHER COMPOSITIONS
PT1000048E (en) SUBSTITUTED DERIVATIVES OF 1,2,3,4-TETRAHYDROFOLATALENE
FI956228L (en) Compositions intended for inhalation
HUP9801900A3 (en) 2-methoxybenzophenone derivatives, intermediates, preparation thereof and fungicide compositions containing them
DE69907964D1 (en) 1,2-FELLENED CHINOLINE DERIVATIVES
FI20095804A7 (en) Benzothiophene compounds, intermediates, compositions and methods
FI903685A7 (en) Aqueous coating compositions
FR2768916B1 (en) TIBIAL OSTEOTOMY STAPLE
FI972309L (en) 2-Heterocyclyloxy- and thiomethyl-1,2,5-thiadizolidin-3-one-1,1-dioxides, compositions containing them and method for their preparation
PT946100E (en) HERBICIDAL COMPOSITIONS CONTAINING N-¬ (4,6-DIMETOXYPYRIMIDIN-2-YL) AMINOCARBONYL-5-METHYLSULFONAMIDOMETHYL-2-ALCOXYCARBONYLENZENESULFONAMIDES
FI972308L (en) 2-substituted 1,2,5-thiadiazolidin-3-one-1,1-dioxides and compositions containing them and methods for using them
PT921125E (en) DERIVATIVES OF 1,38-TRIAZA-ESPIRO 4,5 DECAN-4-ONA
DE69812371D1 (en) FUNGICIDE COMBINATIONS CONTAINING PHENYLACRYLIC ACID DERIVATIVES
NO993460D0 (en) Paroxetine compositions
NO20003105D0 (en) Phenylaminoalkylcarboxylic acid derivatives as well as medical compositions comprising such
FI972306L (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one-1,1-dioxide derivatives and compositions containing them and methods for using them
DE69500604D1 (en) Aqueous primer composition
FI956015L (en) Use of 5-acyl-1,4-dihydropyridines
PT963985E (en) DERIVATIVES OF DI- OR TRIOZA-ESPIRO (4,5) DEAN
ATE238335T1 (en) 5' DEOXYCYTIDINE DERIVATIVES
DK1060162T3 (en) Derived from azacycloalkanes, urethanes, their thio and dithio analogs, their preparation and their use as 2,3-epoxyqualene-lanosterol cyclase inhibitors
NO980595D0 (en) Biocidal compositions
ATE243218T1 (en) 2''-DEOXYHYGROMYCIN DERIVATIVES
DE60015133D1 (en) SYNERGISTIC COMPOSITION OF BIOCIDES
PT796843E (en) DERIVATIVES OF 1,25-DIHYDROXY-16,22,23-TRISDE-HYDRO-COLECALCIFEROL